"Biphasic Insulins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An insulin preparation that is designed to provide immediate and long term glycemic control in a single dosage. Biphasic insulin typically contains a mixture of REGULAR INSULIN or SHORT-ACTING INSULIN combined with a LONG-ACTING INSULIN.
Descriptor ID |
D061265
|
MeSH Number(s) |
D06.472.699.587.200.200 D12.644.548.586.200.200 D26.310.249
|
Concept/Terms |
Biphasic Insulins- Biphasic Insulins
- Insulins, Biphasic
- Biphasic Insulin
- Insulin, Biphasic
- Insulin Mixtures
- Mixed Insulins
- Insulins, Mixed
|
Below are MeSH descriptors whose meaning is more general than "Biphasic Insulins".
Below are MeSH descriptors whose meaning is more specific than "Biphasic Insulins".
This graph shows the total number of publications written about "Biphasic Insulins" by people in this website by year, and whether "Biphasic Insulins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Biphasic Insulins" by people in Profiles.
-
Severe autoimmune insulin resistance--a case report. QJM. 2014 Dec; 107(12):1019-21.
-
Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US. Diabetes Obes Metab. 2007 Jan; 9(1):103-13.
-
Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab. 2006 Jan; 8(1):58-66.
-
Assessing the role of biphasic insulin aspart 30 as an effective and tolerable front-line therapy for type 2 diabetes. Clin Ther. 2005; 27 Suppl B:S39-41.